menopause estrogen venous events meve study retrospective observational study menopausal hormone therapy venous thromboembolism vte postmenopausal women previous history found transdermal estradiol associated increased risk vte hrtooltip hazard ratio citooltip confidence interval whereas oral estrogens associated large increase risk hr ci mean dose transdermal estradiol study Î¼gday although data dose missing around similarly small study found transdermal estradiol influence coagulation women prior findings similar studies menopausal women without prior history vte found transdermal estradiol minimal influence associated increased risk vte doses menopausal hormone therapy guidelines cited meve study recommended use transdermal estradiol oral estrogens women high risk however randomized controlled trials rcts still needed definitively confirm findings transdermal estradiol safer oral estrogens terms vte